Tumblelog by Soup.io
Newer posts are loading.
You are at the newest post.
Click here to check if anything new just came in.
billing4763

Hamas Prime Minister?s Granddaughter Receives Medical Treatment In Israel

Medical body to join review plea in negligence case

A statement from a defense agency says the one-year-old girl came to Israel on Sunday in grave condition, and returned to Gaza on Monday after doctors determined they could not help her. Michael Birnbaum Decades after the fearsome secret police were disbanded, victims say Stasi did far more damage to lives. Soldier: Minneapolis man ordered Nazi-led attack David Rising and Randy Herschaft Newly uncovered testimony belies statements by the mans family that he had no role in any Nazi crimes. Syrian rebel leader dies of wounds from airstrike Liz Sly and Loveday Morris The death of the Tawheed Brigades Abdul Qader Saleh is a blow to rebels in the face of government gains. In Gaza, the girls father, Abdel Salem Haniyeh, wrote on his Facebook page Tuesday that the girl was clinically dead with brain damage. He said he was praying for her. Prime Minister Ismail Haniyehs office declined comment. But a family friend said the move had no political significance. He spoke on condition of anonymity because he wasnt authorized to discuss the matter with media. Although Hamas and Israel are enemies, Gazans often receive medical treatment in Israel. Copyright 2013 The Associated Press. All rights reserved.
Source: http://www.washingtonpost.com/world/middle_east/hamas-prime-ministers-granddaughter-receives-medical-treatment-in-israel/2013/11/19/3f8def52-511a-11e3-9ee6-2580086d8254_story.html

Pa. medical marijuana bill has bi-partisan support

Sens. Daylin Leach, D-Montgomery, and Mike Folmer, R-Lebanon, said their bill would help ensure Pennsylvanians can get medical benefits from cannabidiol, or CBD, a compound found in marijuana that is credited with various medical applications without providing a high. It is the first time that a medical marijuana bill has been drafted with bipartisan support in the Senate, Leach said. Under the bill, Pennsylvania doctors would be limited to prescribing medicine derived from marijuana that has a higher amount of CBD than marijuana's psychoactive chemical, known as THC, Leach said. It would not be addictive or psychoactive, and could be used in place of pharmaceuticals that are toxic, addictive or riddled with side effects, Leach said. "There is no rational reason not to support giving a child this medication," Leach told a Capitol news conference packed with supporters of legalizing medical marijuana. It can be delivered by dropper for children and pill form for adults. Two Pennsylvania mothers of children with epilepsy, including one boy who has a rare and sometimes deadly form called Dravet syndrome, appeared with Leach and said they believe it can control their children's debilitating seizures. "My plea today to the government is to leave the doctoring to the doctors," said Dana Ulrich of Reinholds. She said her daughter Lorelei, 6, suffers some 400 seizures a day.
Source: http://www.businessweek.com/ap/2013-11-19/pa-dot-medical-marijuana-bill-has-bi-partisan-support

Cohera Medical, Inc.® Completes Fourth and Final Module in the Premarket Approval (PMA) Application for TissuGlu® Surgical Adhesive

In the present scenario, the compensation amount awarded by the Supreme Court is huge and unbearable. If it becomes a practice, it would be difficult for the doctors to continue their service. Hence, we decided to take part in the review petition on behalf of the medical practitioners across the country," Saini said. The SC verdict in the medical negligence case dominated the workshop arranged by the Kolhapur medical association (KMA), one of the oldest medical practitioners' organizations in the state, where senior vice president of IMA Maharashtra Vivek Bilampelly expressed strong concerns over the court decision. "Compensation of over Rs 5 crore is unbearable and it will make difficult for the medical practitioners to concentrate on the treatment of the patient," Bilampelly, who practices in Pune, said. President of IMA, Maharashtra branch, Anil Pachnekar told TOI that his branch has discussed the compensation issue and had conveyed its views to IMA. "If we don't discriminate between the patients, the same rule should be applied in the compensation. The compensation verdict may affect the doctors spread in the entire country," he told TOI over phone. Jayant Watve, president of KMA, said that doctors in all parts of the region are worried since the verdict.
Source: http://timesofindia.indiatimes.com/city/kolhapur/Medical-body-to-join-review-plea-in-negligence-case/articleshow/26012301.cms

Shocking Medical Devices From Another Century

Here's how each of them, in his or her own way, is trying to save lives: The problem: In Cameroon, there is only one doctor for every 5,000 people, according to the World Health Organization. For comparison's sake, the ratio in the United States is one doctor for every 413 people. CNN Hero: Dr. Georges Bwelle Jungle medicine And even if they could see a physician, many Cameroonians couldn't afford it. Two out of five people in the country live below the poverty line, and nearly three-quarters of the country's health-care spending is private. "The only problem they have is poverty," Bwelle said. "And with poverty, they ... cannot enjoy their life." How Bwelle took action: Seeing his father and so many of his countrymen suffer, Bwelle was determined to do something about it. He became a doctor himself, working as a vascular surgeon in Yaounde's Central Hospital.
Source: http://www.cnn.com/2013/11/17/health/cnnheroes-medical-marvels/index.html

TOPSHOTS
A man watches as Mount Sinabung continues to erupt, with hot smoke spewing from the volcano, in the Karo district on the north of Indonesia This model was the first made in the U.S. Electroson (1969) This portable Russian electrosleep machine produces low-frequency pulses of electrical current to stimulate the brain during sleep. Alpha-Stim 2000 (1981-1987). Transcutaneous electrical nerve stimulation is a method for passing currents between two electrodes placed on the body. "The Alpha-Stim 2000 is the fastest, most effective method of pain control on the market today," its manual boasts. "Its advanced circuitry uses 1983 electronic technology, and its advanced design utilizes an 'analytical-therapeutic loop' which allows for more operator variables than ever before available." It also weighs more than 40 pounds and cost $5,850, according to the website of EPI, the company that made it and still markets similar products today. EPI's founder, one Dr. Daniel L. Kirsch, explains the scientific rationale behind the Alpha-Stim thusly: "It is based on a theory of cellular resonance or biological harmonics, whatever you want to call it." Any questions? No? Good.
Source: http://www.wired.com/wiredscience/2013/11/bakken-museum/

3 medical marvels saving lives

With operations in more than 50 countries and 30,000 employees worldwide, Avery Dennison serves customers with insights and innovations that help make brands more inspiring and the world more intelligent. Headquartered in Pasadena, California, the company reported sales from continuing operations of $6 billion in 2012. Learn more at www.averydennison.com . About CareFusion CareFusion ( CFN ) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops industry-leading technologies including Alaris infusion pumps, Pyxis automated dispensing and patient identification systems , AVEA , AirLife and LTV series ventilation and respiratory products, ChloraPrep products, MedMined services for data mining surveillance, V. Mueller surgical instruments, and an extensive line of products that support interventional medicine . CareFusion employs approximately 15,000 people across its global operations. More information may be found at www.carefusion.com . Health Care Industry Whether youre buying a home or refinancing, mortgage closing costs are an inevitable part of the transaction.
Source: http://finance.yahoo.com/news/vancive-medical-technologies-carefusion-sign-120000249.html

Vancive Medical Technologies?, CareFusion Sign Agreement for Antimicrobial Dressing

In the pivotal clinical trial, when TissuGlu was used, patients required fewer post-operative treatments and resumed normal activities, such as going to work, showering and using the stairs, more quickly. "Submitting the final module to FDA is a critical milestone in making TissuGlu Surgical Adhesive available to surgeons and patients in the U.S.," said Patrick Daly, President and Chief Executive Officer of Cohera Medical. "The successful completion of this module represents a huge effort on the part of the entire company and we look forward to continuing our work with FDA." Currently, most patients who undergo abdominoplasty procedures or other large flap procedures, such as mastectomy or inguinal lymph node dissection, require the insertion of drains to remove fluid that accumulates under the skin at the surgical site. Drains are often uncomfortable for the patient and can lead to additional complications. TissuGlu forms a strong bond between tissue layers, helping to reduce the fluid that can accumulate during healing. About Cohera Medical Cohera Medical, Inc. is a leading innovator and developer of absorbable surgical adhesives and sealants. The Company's first product, TissuGlu Surgical Adhesive, is an internal surgical adhesive for large flap surgeries, such as abdominoplasty (tummy tuck), that eliminates or reduces fluid accumulation and the need for post surgical drains. TissuGlu's chemical composition is resorbable, non-toxic, forms a strong bond between tissue layers and allows for natural healing, which ultimately may enable faster recovery. TissuGlu has received CE Marking approval to be sold in the European Union (EU). Cohera Medical is also developing a unique and proprietary bowel sealant, and a strong adhesive for mesh fixation. Outside of the EU, TissuGlu and the other Cohera products are currently indicated for investigational use only and have not yet been approved for medical use by the Food and Drug Administration (FDA) in the U.S.
Source: http://finance.yahoo.com/news/cohera-medical-inc-completes-fourth-130300407.html

Don't be the product, buy the product!

Schweinderl